Slideshow
Latest Health Technology at CES 2021
MPR highlights health innovations from the 2021 Consumer Electronics Show (CES).
Your search for hypertension returned 1849 results
News
Experts Weigh In on the Best Diets for 2021
An expert panel assessed 39 diets to come up with the final results, examining the evidence behind each diet’s claims.
News
Gemtesa Approved for Overactive Bladder Treatment
The approval was based on data from the pivotal phase 3 EMPOWUR study.
News
NSAID Use Among US Adults With Cardiovascular Disease Examined
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
Clinical Charts
Decision Pathway for Diabetes and Prediabetes
An algorithm to help guide the interpretation of blood test results in order to identify patients with prediabetes and prevent the development of diabetes.
News
Saxenda Approved for Obesity in Adolescent Patients
The FDA has approved Saxenda® (liraglutide; Novo Nordisk) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients aged 12 years and older with body weight >60kg and an initial BMI corresponding to ≥30kg/m2 for adults (obese).
ASH 2020
Convalescent Plasma for Severe COVID-19: D-Dimer Level After Transfusion May Be a Predictive Biomarker of Mortality
Convalescent plasma therapy may “potentiate the increased thrombotic risk and endotheliopathy” thought to contribute to disease pathophysiology in COVID-19.
Clinical Charts
Arthritis Treatments: DMARDS and Other Immune Modulators
A comparative list of treatment options for arthritis including DMARDS and other immune modulators.
News
Pet Meds Listed in Owner’s Medication Profile Lead to Confusion in the ED
The patient, a 67-year-old female, presented to the emergency department with altered mental status.
News
Gavreto Gets Accelerated Approval for RET-Altered Thyroid Cancers
The approval was based on data from the phase 1/2 ARROW trial which evaluated the efficacy and safety of Gavreto in patients with RET-mutant MTC.
